We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
Turnover
16.91%
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$127M
AUM Growth
+$5.97M
(+4.9%)
Cap. Flow
+$2.28M
Cap. Flow
% of AUM
1.8%
Top 10 Holdings %
Top 10 Hldgs %
33.47%
Holding
138
New
8
Increased
26
Reduced
58
Closed
12
Avg Time Held Equity + Options
2.5
years
Top 10 Avg Time Held Equity + Options
1.2
years
Top 20 Avg Time Held Equity + Options
1.7
years
Avg Time Held Equity only
2.5
years
Top 10 Avg Time Held Equity only
1.2
years
Top 20 Avg Time Held Equity only
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DigitalBridge
DBRG
|
+$2.89M |
| 2 |
Walgreens Boots Alliance
WBA
|
+$2.35M |
| 3 |
Viasat
VSAT
|
+$1.35M |
| 4 |
iShares Europe ETF
IEV
|
+$810K |
| 5 |
Medical Properties Trust
MPT
|
+$526K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLNY
Colony Capital, Inc.
CLNY
|
+$2.88M |
| 2 |
Citigroup
C
|
+$803K |
| 3 |
AERI
Aerie Pharmaceuticals
AERI
|
+$526K |
| 4 |
FGH
FG Group Holdings Inc.
FGH
|
+$384K |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$369K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.36% |
| 2 | Real Estate | 16.33% |
| 3 | Healthcare | 15.71% |
| 4 | Technology | 14.05% |
| 5 | Financials | 10.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Ally Financial
ALLY
$11.5B
| $376K | 0.3% |
18,500
-500
| -3% | -$10.6K |
2015 Q3
6 quarters
|
|
77
American International
AIG
$41.4B
| $375K | 0.3% |
6,000
-1,500
| -20% | -$96.3K |
2013 Q2
15 quarters
|
|
78
Colgate-Palmolive
CL
$73.9B
| $366K | 0.29% |
5,000
| – | – |
2013 Q2
15 quarters
|
|
79
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $366K | 0.29% |
5,800
+625
| +12% | +$46.3K |
2016 Q1
4 quarters
|
|
80
DELISTED
PIMCO Dynamic Credit and Mortgage Income Fund
PCI
| $330K | 0.26% |
15,400
-500
| -3% | -$10.4K |
2014 Q4
9 quarters
|
|
81
Vanguard Real Estate ETF
VNQ
$36.7B
| $315K | 0.25% |
3,815
-500
| -12% | -$41.5K |
2013 Q4
13 quarters
|
|
82
Vanguard Morningstar Total Stock Market ETF
VTI
$697B
| $307K | 0.24% |
2,530
-50
| -2% | -$5.99K |
2013 Q2
15 quarters
|
|
83
Kayne Anderson Energy Infrastructure Fund
KYN
$2.36B
| $304K | 0.24% |
14,500
-3,200
| -18% | -$65.9K |
2013 Q2
15 quarters
|
|
|
MIN
84
Aberdeen Intermediate Income Fund
MIN
$267M
| $301K | 0.24% |
11,633
+250
| +2% | +$6.51K |
2013 Q2
15 quarters
|
|
85
Verizon
VZ
$184B
| $296K | 0.23% |
6,068
+323
| +6% | +$16.2K |
2014 Q3
10 quarters
|
|
86
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$328M
| $274K | 0.22% |
7,000
| – | – |
2016 Q4
1 quarter
|
|
87
Kratos Defense & Security Solutions
KTOS
$7.65B
| $272K | 0.21% |
35,000
| – | – |
2013 Q2
15 quarters
|
|
88
CPI Aerostructures
CVU
$65.9M
| $269K | 0.21% |
39,800
-1,600
| -4% | -$12.7K |
2013 Q4
13 quarters
|
|
89
iShares Core High Dividend ETF
HDV
$15.4B
| $268K | 0.21% |
+16,000
| New | +$267K |
2017 Q1
0 quarters
|
|
90
DELISTED
Tsakos Energy Navigation Limited
TNP.PRB.CL
| $259K | 0.2% |
10,100
-200
| -2% | -$5.09K |
2013 Q2
15 quarters
|
|
91
FedEx
FDX
$69.9B
| $254K | 0.2% |
1,300
| – | – |
2016 Q3
2 quarters
|
|
|
TWX
92
DELISTED
Time Warner Inc
TWX
| $254K | 0.2% |
+2,600
| New | +$252K |
2017 Q1
0 quarters
|
|
93
Invesco QQQ Trust
QQQ
$487B
| $252K | 0.2% |
1,900
| – | – |
2015 Q3
6 quarters
|
|
94
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
| $251K | 0.2% |
3,375
-100
| -3% | -$7.29K |
2014 Q4
9 quarters
|
|
95
INNOVATE Corp
VATE
$84.7M
| $248K | 0.2% |
4,000
+500
| +14% | +$31K |
2016 Q3
2 quarters
|
|
96
DELISTED
Goldman Sachs Group Depositary Shares (1/1000 Interest of 6.2% Non-Cum. Prfrd. Stock, Series B) Call
GS.PRB.CL
| $245K | 0.19% |
9,200
-500
| -5% | -$13K |
2014 Q1
12 quarters
|
|
|
TRIB
97
Trinity Biotech
TRIB
$6.45M
| $241K | 0.19% |
270
-47
| -15% | -$44.1K |
2013 Q2
15 quarters
|
|
98
Annaly Capital Management
NLY
$13.9B
| $239K | 0.19% |
5,375
-600
| -10% | -$25.5K |
2013 Q2
15 quarters
|
|
99
Celldex Therapeutics
CLDX
$2.27B
| $234K | 0.18% |
4,320
-133
| -3% | -$6.93K |
2015 Q4
5 quarters
|
|
100
Sarepta Therapeutics
SRPT
$1.88B
| $222K | 0.18% |
7,500
| – | – |
2013 Q2
15 quarters
|
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Benchmark Capital Advisors held 138 positions worth $127M, up 4.9% from $121M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Benchmark Capital Advisors's Q1 2017 filing shows 8 new, 26 increased, 58 reduced and 12 closed positions. Its largest new stake was DigitalBridge: 51,490 shares worth $2.66M. The largest sale was Colony Capital, Inc., an estimated $2.88M.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, up from 19% a quarter earlier, followed by Real Estate and Healthcare.
- Benchmark Capital Advisors's largest Q1 2017 buy was DigitalBridge: 51,490 shares worth $2.66M.
- Benchmark Capital Advisors added most to Walgreens Boots Alliance in Q1 2017, an estimated $2.35M increase.
- Benchmark Capital Advisors's biggest Q1 2017 reduction was Citigroup, cutting an estimated $803K.
- Benchmark Capital Advisors fully exited Colony Capital, Inc. in Q1 2017, selling an estimated $2.88M.
- Benchmark Capital Advisors's ten largest holdings make up 33% of its $127M portfolio in Q1 2017.
- Benchmark Capital Advisors opened 8 new positions and closed 12 in Q1 2017.
- Benchmark Capital Advisors's portfolio value rose 4.9% quarter-over-quarter to $127M.
Based on Benchmark Capital Advisors's 13F filing for Q1 2017, filed 9 May 2017.